Investment thesis
Early-stage advanced therapies: cell therapy, gene therapy, RNA-based therapy, targeted therapies and microbiome-based treatments
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| Aptadir Therapeutics Milan, Italy | Seed | Sep 2026 | €40M |
By deadline
Latest
Aptadir raises €40M seed to switch silenced genes back onRayon raises €10M Series A to bring 3D and AI to interior designIPercept raises $16.5M Series A to give CNC machines a health checkbilt.me raises $700K pre-seed to turn prompts into mobile appsAll funding coverage →Browse the database
Latest
Bessemer Venture Partners closes $5.75B, mostly for growthQuantumLight Closes $500M Fund II – and Algorithmic VC Stops Being an ExperimentThe EIF’s €15B ETCI 2 Is Europe’s Biggest Bet Yet on Fixing the Scaleup GapEuropean Sustainable Investment Summit London 2020All investors coverage →By ticket size
By country
Early-stage advanced therapies: cell therapy, gene therapy, RNA-based therapy, targeted therapies and microbiome-based treatments
| Company | Round | Date | Round size |
|---|---|---|---|
| Aptadir Therapeutics Milan, Italy | Seed | Sep 2026 | €40M |